The Library
Practical guidance on the role of corticosteroids in the treatment of metastatic castration-resistant prostate cancer
Tools
De Santis, Maria and Saad, Fred (2016) Practical guidance on the role of corticosteroids in the treatment of metastatic castration-resistant prostate cancer. Urology, 96 . pp. 156-164. doi:10.1016/j.urology.2016.02.010 ISSN 0090-4295.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1016/j.urology.2016.02.010
Abstract
Corticosteroids have been used in combination with chemotherapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC) for more than three decades, particularly to treat pain, inflammation, and edema. More recently, they have been used in combination with hormonal agents. The importance of corticosteroids in mCRPC is due to their ability to manage adverse effects, reduce symptoms, and improve patients' quality of life. The appropriate selection of available options in mCRPC should be based on careful consideration of a patient's profile and comorbidities. This review provides an overview of the role of corticosteroids in treating mCRPC for the practicing urologist.
Item Type: | Journal Article | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||||||||
Journal or Publication Title: | Urology | ||||||||||
Publisher: | Elsevier Inc. | ||||||||||
ISSN: | 0090-4295 | ||||||||||
Official Date: | October 2016 | ||||||||||
Dates: |
|
||||||||||
Volume: | 96 | ||||||||||
Page Range: | pp. 156-164 | ||||||||||
DOI: | 10.1016/j.urology.2016.02.010 | ||||||||||
Status: | Peer Reviewed | ||||||||||
Publication Status: | Published | ||||||||||
Access rights to Published version: | Open Access (Creative Commons) |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |